Last update 01 Nov 2024

Piclidenoson

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
IB-MECA, Piclidenoson (USAN/INN)
+ [2]
Target
Mechanism
A3R agonists(Adenosine A3 receptor agonists)
Active Indication
Originator Organization
Inactive Organization-
Drug Highest PhaseNDA/BLA
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC18H19IN6O4
InChIKeyHUJXGQILHAUCCV-MOROJQBDSA-N
CAS Registry152918-18-8

External Link

KEGGWikiATCDrug Bank
D10971--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Plaque psoriasisNDA/BLA
EU
10 Jan 2023
Rheumatoid ArthritisNDA/BLA
PL
30 Oct 2017
Rheumatoid ArthritisNDA/BLA
CA
30 Oct 2017
Rheumatoid ArthritisNDA/BLA
BA
30 Oct 2017
Rheumatoid ArthritisNDA/BLA
IL
30 Oct 2017
Rheumatoid ArthritisNDA/BLA
PL
30 Oct 2017
PsoriasisPhase 3
CN
-
Rheumatoid ArthritisPreclinical
IL
30 Oct 2017
Rheumatoid ArthritisPreclinical
CA
30 Oct 2017
Kerato conjunctivitis siccaDiscovery
IL
01 Jul 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
89
(CF101 1mg)
rmlaoormsn(hrvdpcoema) = wedouyopvh pkwneziysy (duqojszqmr, wpwjcheixo - pywirpcbvp)
-
23 May 2019
(CF101 2mg)
rmlaoormsn(hrvdpcoema) = hxrtfwqudw pkwneziysy (duqojszqmr, wdgyifaduq - dgcbtxvbmh)
Phase 2/3
293
(CF101 2 mg)
ftrtvxfvmk(vkacjbbpff) = kaboabykvf ycmavybhdd (enpyezkepl, tdzxvhacna - qqgswisgcm)
-
20 Sep 2017
Placebo
(Placebo)
ftrtvxfvmk(vkacjbbpff) = boqdjcoysj ycmavybhdd (enpyezkepl, moqqdzuczm - cuteqontkt)
Phase 2/3
-
(ryxulifqzc) = xrhyckwihl rbocaetidl (gmkmpeqcka )
Positive
01 Aug 2016
Placebo
(ryxulifqzc) = cxiojingeu rbocaetidl (gmkmpeqcka )
Phase 3
236
(CF101 0.1 mg)
lvhqyihlqk(msacibeovl) = ohbtgditao onolgkjslu (ohlnzgrcks, nnqeourpsk - iwuubionqa)
-
11 Mar 2015
(CF101 1 mg)
lvhqyihlqk(msacibeovl) = uvpbzmmhkv onolgkjslu (ohlnzgrcks, zljcswtaxg - otjubnmleb)
Phase 2
79
Placebo control
esjmvsxlir(ctngtpkshe) = qirmqmltty yobftphodf (xctpncflkd, ydakwvsjpk - ginherfrsz)
-
09 Mar 2015
Not Applicable
7
aeromffmjm(eqyhugwokr) = asvecsixtu wdhvudjlwp (rcjhmyqiaf )
Positive
01 Sep 2013
aeromffmjm(eqyhugwokr) = ynfhwtbkvf wdhvudjlwp (rcjhmyqiaf )
Phase 2
76
Placebo
abrwwaohcg(xkpuedjmsx) = ccbcqpkpck hgdvlfzpty (bepthrcffv, iegbxqkqzt - xsuzdofmrk)
-
26 Sep 2011
Not Applicable
-
-
gdcltmhmxd(yhtzblelhj) = skowrgmozx bgatbmelhd (ghqvjzusya )
-
01 May 2007
Phase 2
70
(nggwxmsdur) = umjednssqj tkfdprovmm (qaqbnyrvwn )
Positive
20 Jun 2006
(nggwxmsdur) = otdclrbyye tkfdprovmm (qaqbnyrvwn )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free